XML 31 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2018
Dec. 31, 2017
Current Assets:    
Cash and cash equivalents $ 542.8 $ 524.4
Accounts receivable, less allowance for doubtful accounts 1,275.8 1,544.1
Inventories 2,256.5 2,068.3
Prepaid expenses and other current assets 352.3 428.0
Total Current Assets 4,427.4 4,564.8
Property, plant and equipment, net 2,015.4 2,038.6
Goodwill 9,594.4 10,668.4
Intangible assets, net 7,684.6 8,353.4
Other assets 405.0 388.8
Total Assets 24,126.8 26,014.0
Current Liabilities:    
Accounts payable 362.6 330.2
Income taxes payable 142.4 165.2
Other current liabilities 1,391.3 1,349.3
Current portion of long-term debt 525.0 1,225.0
Total Current Liabilities 2,421.3 3,069.7
Deferred income taxes, net 999.5 1,101.5
Long-term income tax payable 666.2 744.0
Other long-term liabilities 350.0 445.8
Long-term debt 8,413.7 8,917.5
Total Liabilities 12,850.7 14,278.5
Commitments and Contingencies (Note 19)
Stockholders' Equity:    
Common stock, $0.01 par value, one billion shares authorized, 307.9 million (306.5 million in 2017) issued 3.1 3.1
Paid-in capital 8,686.1 8,514.9
Retained earnings 9,491.2 10,022.8
Accumulated other comprehensive loss (187.4) (83.2)
Treasury stock, 103.9 million shares (103.9 million shares in 2017) (6,721.7) (6,721.8)
Total Zimmer Biomet Holdings, Inc. stockholders' equity 11,271.3 11,735.8
Noncontrolling interest 4.8 (0.3)
Total Stockholders' Equity 11,276.1 11,735.5
Total Liabilities and Stockholders' Equity $ 24,126.8 $ 26,014.0